|
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
RECRUITINGN/ASponsored by Memorial Sloan Kettering Cancer Center
Actively Recruiting
PhaseN/A
SponsorMemorial Sloan Kettering Cancer Center
Started2026-01-23
Est. completion2029-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT07225088
Summary
The purpose of this study is to improve ways of providing mental health support to Spanish-speaking Latino participants who have cancer and experience depression, insomnia, and fatigue. Investigators will test a special mental health intervention called DESCANSO/REST (Depresión/Depressed Mood, Cansancio/Fatigue, and Sueño/Sleep). The intervention can be delivered through telehealth.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Provider Eligibility Criteria: Participant eligibility will be determined by a self-report screener. Inclusion Criteria Self-Report Criteria * Mental health provider * Treats Latino cancer patients and/or survivors * Has at least 3 years of clinical experience providing psychosocial services to cancer patients and/or survivors * Able to read Spanish determined by the question: "Can you read in Spanish? Yes/No" Patient Eligibility Criteria: A patient cannot be considered eligible for this study unless ALL of the following conditions are met. Participant eligibility will be determined by an initial EMR review followed by a self-report screener. Inclusion Criteria EMR Criteria * Documentation of Disease o Pathologically confirmed solid tumor cancer (either most recent or new diagnosis) * Definition of Disease \[or Measurable Disease\] o Diagnosed with stages I, II, or III * Prior Treatment * Currently undergoing systemic therapy (chemotherapy, radiation therapy, and/or immunotherapy) or within the first year following completion of systemic therapy Self-Report Criteria * Age ≥ 21 years * Lives in mainland U.S. or Puerto Rico * Identifies as Latino/a or Hispanic * Reports Spanish as their preferred language * Speaks Spanish "Very well" or "Well" as determined by the question: "How well do you speak Spanish?" * Presence of fatigue and disturbed sleep determined by a score of ≥ 3 on the MD Anderson Symptom Inventory Exclusion Criteria EMR Criteria o In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation Self-Report Criteria * History of comorbidities within the last 12 months associated with fatigue and poor sleep, including hypothyroidism or abnormal thyroid function, sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, alcohol or drug abuse * Pregnant or lactating, women only * Presence of suicidal risk determined by any affirmative response on the Columbia-Suicide Severity Rating Scale
Conditions4
CancerDepressionSolid TumorSolid Tumor, Adult
Locations7 sites
Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities)
Basking Ridge, New Jersey, 07920
Rosario Costas Muniz, PhD646-888-8062
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, New Jersey, 07748
Rosario Costas Muniz, PhD646-888-8062
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey, 07645
Rosario Costas Muniz, PhD646-888-8062
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity)
Commack, New York, 11725
Rosario Costas Muniz, PhD646-888-8062
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, New York, 10604
Rosario Costas Muniz, PhD646-888-8062
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorMemorial Sloan Kettering Cancer Center
Started2026-01-23
Est. completion2029-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT07225088